康方生物:持续深耕肿瘤治疗领域

经济参考网
Nov 28, 2025

康方生物(09926.HK)创始人、董事长夏瑜在11月25日举行的“2025第十七届中国医药企业家科学家投资家大会中国医药创新趋势论坛”上表示,公司将持续深耕肿瘤治疗领域,同时拓展多疾病赛道,让中国创新药惠及更多患者。随着全球研发资源的持续投入和技术路径的不断革新,肿瘤免疫治疗将继续引领生物医药产业的发展方向。在这一关键赛道上,中国创新力量表现突出。夏瑜称,康方生物将肿瘤免疫治疗的发展划分为两个...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10